CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
-3.29%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$1.04B
AUM Growth
+$1.04B
(-5.3%)
Cap. Flow
-$3.43M
Cap. Flow
% of AUM
-0.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
GRTS
Gritstone bio, Inc. Common Stock
GRTS
|
$3.43M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $448M | 42.88% | 15,396,116 | – | – |
|
2
Nurix Therapeutics
NRIX
$714M
| $167M | 16.04% | 5,383,333 | – | – |
|
3
Revolution Medicines
RVMD
$7.1B
| $164M | 15.74% | 3,580,252 | – | – |
|
4
Oric Pharmaceuticals
ORIC
$994M
| $117M | 11.19% | 4,768,181 | – | – |
|
5
RAPT Therapeutics
RAPT
$188M
| $86.3M | 8.26% | 3,885,679 | – | – |
|
|
CNST
6
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $61.4M | 5.89% | 2,626,631 | – | – |
|
|
GRTS
7
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – | -869,493 | Closed | -$3.43M |
|